ARYA Sciences Acquisition Corp V (Nasdaq: ARYE) is a blank-check company sponsored by ARYA Sciences Holdings V LLC, an affiliate of Perceptive Advisors, a life-sciences-focused investment firm. The company priced its initial public offering in 2021 and targets the life sciences and biotechnology sector, consistent with the broader ARYA Sciences SPAC franchise, which has launched multiple acquisition vehicles focused on early-stage healthcare and biotech companies. As of its Form 10-Q filed November 7, 2022, the company remained in its search phase, evaluating potential business combination candidates in the life sciences space. Sign up at SpacDesk to access complete filing histories, deal timelines, and sponsor analytics on ARYE and the broader SPAC market.